1. Home
  2. TRVI vs GCT Comparison

TRVI vs GCT Comparison

Compare TRVI & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • GCT
  • Stock Information
  • Founded
  • TRVI 2011
  • GCT 2019
  • Country
  • TRVI United States
  • GCT United States
  • Employees
  • TRVI N/A
  • GCT N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • GCT Catalog/Specialty Distribution
  • Sector
  • TRVI Health Care
  • GCT Consumer Discretionary
  • Exchange
  • TRVI Nasdaq
  • GCT Nasdaq
  • Market Cap
  • TRVI 725.7M
  • GCT 798.3M
  • IPO Year
  • TRVI 2019
  • GCT 2022
  • Fundamental
  • Price
  • TRVI $7.42
  • GCT $28.91
  • Analyst Decision
  • TRVI Strong Buy
  • GCT Buy
  • Analyst Count
  • TRVI 9
  • GCT 2
  • Target Price
  • TRVI $19.50
  • GCT $20.50
  • AVG Volume (30 Days)
  • TRVI 1.8M
  • GCT 772.4K
  • Earning Date
  • TRVI 08-07-2025
  • GCT 08-07-2025
  • Dividend Yield
  • TRVI N/A
  • GCT N/A
  • EPS Growth
  • TRVI N/A
  • GCT 19.25
  • EPS
  • TRVI N/A
  • GCT 3.31
  • Revenue
  • TRVI N/A
  • GCT $1,193,610,000.00
  • Revenue This Year
  • TRVI N/A
  • GCT $1.98
  • Revenue Next Year
  • TRVI N/A
  • GCT $6.50
  • P/E Ratio
  • TRVI N/A
  • GCT $8.73
  • Revenue Growth
  • TRVI N/A
  • GCT 21.20
  • 52 Week Low
  • TRVI $2.36
  • GCT $11.17
  • 52 Week High
  • TRVI $8.11
  • GCT $29.20
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 59.47
  • GCT 77.15
  • Support Level
  • TRVI $7.08
  • GCT $20.71
  • Resistance Level
  • TRVI $7.74
  • GCT $22.13
  • Average True Range (ATR)
  • TRVI 0.42
  • GCT 1.28
  • MACD
  • TRVI -0.05
  • GCT 0.20
  • Stochastic Oscillator
  • TRVI 55.77
  • GCT 99.15

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.

Share on Social Networks: